About Ajanta Pharma Ltd. 
Ajanta Pharma Ltd.
Mid Cap
Pharmaceuticals & Biotechnology
Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa. The Company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets. It produces a comprehensive range of specialty products targeting different therapeutic segments.
Company Coordinates 
Company Details
Ajanta House, Charkop Kandivli (W) Mumbai Maharashtra : 400067
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital Structure 
Present Equity Capital
INR 24.98 Cr
Number of Shares
12.49 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Jul-2024
12.49
24.98
24325
2
Issued under ESOP Scheme
27-Jun-2024
12.49
24.98
-1028881
2
Buy Back of Shares
02-May-2024
12.59
25.18
1000
2
Issued under ESOP Scheme
05-May-2023
12.81
25.63
1000
2
Issued under ESOP Scheme
05-May-2023
12.59
25.18
1000
2
Issued under ESOP Scheme
19-Apr-2023
12.59
25.18
-2210500
2
Buy Back of Shares
22-Jun-2022
12.81
25.63
42708385
2
Bonus Issue
10-May-2022
8.54
17.08
1000
2
Issued under ESOP Scheme
26-Feb-2022
8.54
17.08
-1120000
2
Buy Back of Shares
24-Sep-2021
8.65
17.31
4000
2
Issued under ESOP Scheme
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
15.2771
Mutual Funds
Held by 29 Schemes (14.67%)
FIIs
Held by 282 FIIs (8.53%)
Promoter with highest holding
Rajesh M Agrawal, Trustee Rajesh Agrawal Trust (14.47%)
Highest Public shareholder
Uti-flexi Cap Fund (3.12%)
Individual Investors Holdings
6.53%
Management
Designation
Remuneration
Mannalal B Agrawal
Chairman (Non-Executive)
7.04 lacs
Madhusudan B Agrawal
Vice Chairman
3.62 cr
Yogesh Agrawal
Managing Director
15.63 cr
Chandrakanth M Khetan
Independent Director
11.87 lacs
Gaurang Shah
Vice President & CS
0
Rajesh M Agrawal
Joint Managing Director
15.63 cr
K H Viswanathan
Independent Director
9.23 lacs
Prabhakar Dalal
Independent Director
8.33 lacs
Anjana Grewal
Independent Director
7.49 lacs
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Stock-in-Trade
149.04
0%
Purchase of Stock-in-Trade
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Products
1,493.94
84.28%
Pharmaceutical Products - Traded
237.42
13.39%
Other Operating Revenues - Export Incentives
38.93
2.20%
Pharmaceutical Products
Pharmaceutical Products
Pharmaceutical Products - Traded
Pharmaceutical Products - Traded
Other Operating Revenues - Export Incentives
Other Operating Revenues - Export Incentives
Revenue and Profits:
Net Sales:
1,354 Cr
(Quarterly Results - Sep 2025)
Net Profit:
260 Cr
Pharmaceuticals & Biotechnology
INR 32,862 Cr (Mid Cap)
34.00
34
1.07%
-0.16
22.56%
7.59






